Ashfaq Parkar is an accomplished inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of acute kidney injury.

Latest Patents

Parkar holds a patent for a compound known as {4-[5-(3-chloro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-2,6-dimethyl-phenoxy}-acetic acid. This compound is designed for use in the prevention or treatment of acute kidney injury (AKI). The patent also covers a pharmaceutically acceptable salt of this compound, along with its medicament and pharmaceutical composition.

Career Highlights

Currently, Ashfaq Parkar is employed at Sanofi, a leading global healthcare company. His work focuses on developing innovative solutions to address critical health issues, particularly those related to kidney health.

Collaborations

Throughout his career, Parkar has collaborated with notable colleagues, including Véronique Briand and Sabine Gratzer. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Ashfaq Parkar's contributions to the field of pharmaceuticals, particularly through his patent for a compound aimed at treating acute kidney injury, highlight his innovative spirit and dedication to improving healthcare. His work at Sanofi and collaborations with esteemed colleagues further underscore his impact in the industry.

Profile summary based on public USPTO records.